Document is current
Any future updates will be listed below
-
Authors
Hemminki, Kari http://orcid.org/0000-0002-2769-3316
Srivastava, Aayushi
Rachakonda, Sivaramakrishna
Bandapalli, Obul
Nagore, Eduardo
Hemminki, Akseli
Kumar, Rajiv
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (856620)
Jane ja Aatos Erkon Säätiö
EVO
Sigrid Juselius Foundation
Suomen Ihotautilääkäriyhdistys
Helsingin Yliopisto
The Finnish Society of Sciences And Letters
- License Information
-
More Information
Article History
Received: 2 May 2020
Accepted: 21 July 2020
First Online: 31 July 2020
Consent for publication
: Not applicable.
: A.H. is a shareholder in Targovax ASA. A.H. is an employee and shareholder in TILT Biotherapeutics Ltd. Other authors declared no conflict of interest.
